Elaidi, R., Harbaoui, A., Beuselinck, B., Eymard, J..-C.., Bamias, A., De Guillebon, E., Porta, C., Vano, Y., Linassier, C., Debruyne, P. R., Gross-Goupil, M., Ravaud, A., Aitelhaj, M., Marret, G. and Oudard, S. (2014) Outcomes from second-line therapy in long-term responders to first-line tyrosine kinase inhibitor in clear-cell metastatic renal cell carcinoma. Annals of Oncology, 26 (2). pp. 378-385. ISSN 0923-7534 (Print), 1569-8041 (Online) (doi:10.1093/annonc/mdu552)

Cornelis, N., Vermassen, T., Schallier, D., Machiels, J.-P., Gil, T., Debruyne, P. R., D’hondt, R., Bols, A., Schrijvers, D., Mebis, J., Lumen, N. and Rottey, S. (2014) Prospective non-interventional multicentre observational trial of first-line anti-cancer treatment in patients with metastatic renal cell cancer in Belgium. Acta Clinica Belgica, 69 (5). pp. 335-340. ISSN 1784-3286 (doi:10.1179/2295333714Y.0000000051)

Debruyne, P. R., Knott, V. E. and Weller, D. (2014) Themes for our journal: 2014-2016 [Editorial]. European Journal of Cancer Care, 23 (3). pp. 285-287. ISSN 09615423 (Print), 1365-2354 (Online) (doi:10.1111/ecc.12202)

Van Den Broucke, J., Verhaeghe, A., Debruyne, P. R. and Verhelle, K. (2014) [(Added) Value of a clinical pharmacist in the oncology department and optimalisation of the applicability of geriatric tools assessing potential inappropriate medication use in geriatric patients (Drug Burden Index and de Beers criteria)]. Journal de pharmacie de Belgique (1). pp. 28-36. ISSN 0047-2166

Pottel, L., Lycke, M., Boterberg, T., Pottel, H., Goethals, L., Duprez, F., Van Den Noortgate, N., De Neve, W., Rottey, S., Geldhof, K., Buyse, V., Kargar-Samani, K., Ghekiere, V. and Debruyne, P. R. (2014) Serial comprehensive geriatric assessment in elderly head and neck cancer patients undergoing curative radiotherapy identifies evolution of multidimensional health problems and is indicative of quality of life. European Journal of Cancer Care, 23 (3). pp. 401-412. ISSN 0961-5423 (Print), 1365-2354 (Online) (doi:10.1111/ecc.12179)